Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
abnormal, accidental, allele, Alnylam, alongside, anesthesiologist, ATTRv, ATTRwt, baseline, Basta, biosimilar, Blackstone, BridgeBio, bridging, Britain, Carolina, caution, Cellex, certified, coagulation, Colorado, commandeered, contrary, deeper, difficulty, dismissed, Dresden, England, GEMoaB, Germany, GmbH, goodwill, Great, headquartered, inconsistent, interchangeability, interchangeable, intravenously, Ireland, Jersey, Journal, Nerve, NewCo, Nordisk, North, Novo, Ohio, pause, Pennsylvania, Peripheral, pertinent, Pfizer, PNS, quick, redefining, refining, resurgence, RevCAR, reversed, run, scenario, screening, Secretary, settled, Society, supplier, switchable, tracing, Tudor, unadjusted, underwritten, undisclosed, UniCAR, vaccinate, verification, verify, Virginia
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view